Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 3 boards, counting each seat separately. Longest: Imunon Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Imunon Inc. June 16, 202691.0%
-
Imunon Inc. June 15, 202391.3%
-
Tempest Therapeutics Inc. June 15, 202393.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 6, 2026 | Imunon Inc. | Grant or award | +13,166 | $0.85 | $11,125 |
| Jul 31, 2026 | Imunon Inc. | Grant or award | +6,934 | $1.59 | $11,025 |
| May 22, 2026 | Imunon Inc. | Grant or award | +5,557 | $2.20 | $12,225 |
| Aug 4, 2025 | Imunon Inc. | Grant or award | +2,248 | $9.20 | $20,682 |
Questions about Christine A. Pellizzari
What boards is Christine A. Pellizzari on?
Christine A. Pellizzari sits on the boards of Imunon Inc., NeuroSense Therapeutics Ltd. and Tempest Therapeutics Inc.
How long has Christine A. Pellizzari served on boards?
Our records show at least 8 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.